Abstract
Susceptibility weighted imaging (SWI) is a recently developed magnetic resonance imaging (MRI) technique that is increasingly being used to narrow the differential diagnosis of many neurologic disorders. It exploits the magnetic susceptibility differences of various compounds including deoxygenated blood, blood products, iron and calcium, thus enabling a new source of contrast in MR. In this review, we illustrate its basic clinical applications in neuroimaging. SWI is based on a fully velocity-compensated, high-resolution, three dimensional gradient-echo sequence using magnitude and phase images either separately or in combination with each other, in order to characterize brain tissue. SWI is particularly useful in the setting of trauma and acute neurologic presentations suggestive of stroke, but can also characterize occult low-flow vascular malformations, cerebral microbleeds, intracranial calcifications, neurodegenerative diseases and brain tumors. Furthermore, advanced MRI post-processing technique with quantitative susceptibility mapping, enables detailed anatomical differentiation based on quantification of brain iron from SWI raw data.
Keywords: Quantitative susceptibility mapping, Brain, Ischemia, Magnetic resonance imaging, Susceptibility weighted imaging
Core tip: Susceptibility weighted imaging has a variety of applications in neuroradiology practice and should be included in routine protocols. It can detect micro- and macrohemorhages and delineate cerebral microvasculature and can also reveal low-flow vascular malformations. It has been proven as a complementary, valuable imaging sequence in the management of stroke patients. It provides differentiation of calcium from hemorrhage in the brain. It plays an important role in the evaluation of traumatic brain injury patients and aids in the characterization and grading of cerebral tumors. Quantitative susceptibility mapping can be applied on many neurodegenerative disorders by assessing brain iron content.
INTRODUCTION
Susceptibility weighted imaging (SWI) is an magnetic resonance imaging (MRI) technique that exploits the magnetic susceptibility differences of various compounds, such as blood, iron, and diamagnetic calcium, thus enabling new sources of MR contrast[1-3].
SWI has been shown to provide clinically useful complementary information to conventional spin-echo MRI sequences. Additionally, through post-processed quantitative susceptibility mapping (QSM) SWI sequences allow data driven research to evaluate compounds that alter the magnetic field of the brain, a strategy most useful in neurodegenerative disorders. In this review, we highlight many clinical applications of SWI in the evaluation and differential diagnosis of diverse central nervous system (CNS) pathologic conditions. We close with an assessment of the future of SWI and QSM.
PRINCIPLES AND TECHNICAL ASPECTS OF SWI
Local magnetic field heterogeneity leading to T2 shortening may be induced by paramagnetic, diamagnetic and ferromagnetic substances and results in signal loss on T2* weighted gradient-echo (GE) sequences (proton relaxation enhancement). The susceptibility effect is most visible in non-refocused GE techniques using long echo times (TE), short flip angles, and high field strengths. Although SWI relies on GE sequences, it has enhanced susceptibility sensitivity compared with conventional T2* weighted GE sequences because it is based on a high-resolution, long TE, flow-compensated, 3D GE imaging technique containing filtered phase information in each voxel[4]. In SWI, the magnitude and phase MR data are brought together and a phase mask is created. Multiplying these with the original magnitude images result in a final magnitude SWI dataset. Both magnitude and phase information are essential for proper tissue characterization, and are brought together to create an SWI image[5]. Finally, these images are further processed with a minimum intensity projection algorithm (minIP) to obtain 3-10 mm thick high signal to noise minIP slabs. These minIP images thereby reveal the continuity of tortuous veins across the slices while attenuating the signal coming from the brain tissue[4]. On magnitude images, the longer TE of the SWI sequence (e.g., 40 ms at 1.5 tesla) compared with conventional GE sequences (TE 25 ms) allows for more phase dispersion and T2 shortening of the protons in the local inhomogenous magnetic field. Thus SWI highlights small changes in susceptibility across a voxel as signal intensity loss. A low flip angle can keep the CSF brighter than the surrounding parenchyma. Consequently, the magnitude image highlights areas with short T2* and leads to lower signal in major veins due to the presence of deoxyhemoglobin[6]. SWI sequence parameters for 1.5 and 3 Tesla Siemens (Erlangen, Germany) and Philips (the Netherlands) magnets are shown in Tables 1-4.
Table 1.
Slab group 1 | |
Slabs | 1 |
Dist. factor | 20% |
Position | L0.0 A16.0 H37.8 |
Orientation | T > C-6.9 |
Phase enc. dir. | R >> L |
Rotation | 90.00 deg |
Phase oversampling | 0% |
Slibe oversampling | 23.10% |
Slices per slab | 104 |
FoV read | 230 mm |
FoV phase | 75% |
Slice thickness | 1.50 mm |
TR | 28 ms |
TE | 20.00 ms |
Averages | 1 |
Concatenations | 1 |
Filter | Prescan normalize |
Matrix size | 256 × 256 |
TA | 4.44 |
PAT | 2 |
Voxel size | 1.0 mm × 0.9 mm × 1.5 mm |
Flip angle | 15 deg |
Dimension | 3D |
Bandwidth | 120 Hz/Px |
Slice resolution | 100% |
Coil elements | HE1-4 |
Table 4.
FoV read | 230 mm |
Slice thickness | 5 mm |
Gap | 0 |
TR | 23 ms |
TE | 20 ms |
Matrix size | 218 × 127 |
TA | 4.08 |
Flip angle | 10 deg |
Coil elements | 8 channel SENSE head coil |
Table 2.
Slab group 1 | |
Slabs | 1 |
Dist. factor | 20% |
Position | L0.0 A16.0 H37.8 |
Orientation | T > C-6.9 |
Phase enc. dir. | R >> L |
Rotation | 90.00 deg |
Phase oversampling | 0% |
Slibe oversampling | 23.10% |
Slices per slab | 104 |
FoV read | 230 mm |
FoV phase | 75% |
Slice thickness | 1.50 mm |
TR | 28 ms |
TE | 20.00 ms |
Averages | 1 |
Concatenations | 1 |
Filter | Prescan normalize |
Matrix size | 256 × 256 |
TA | 4.44 |
PAT | 2 |
Voxel size | 1.0 mm × 0.9 mm × 1.5 mm |
Flip angle | 15 deg |
Dimension | 3D |
Bandwidth | 120 Hz/Px |
Slice resolution | 100% |
Coil elements | HEA; HEP; NE1, 2 |
Table 3.
FoV read | 230 mm |
Slice thickness | 5 mm |
Gap | 0 |
TR | 35 ms |
TE | 50 ms |
Matrix size | 256 x 512 |
TA | 5.15 |
Flip angle | 15 deg |
Coil elements | 8 channel SENSE head coil |
Paramagnetic materials have at least one unpaired electron in the system, but diamagnetic materials have all their electrons paired. Diamagnetic materials are repelled by a magnetic field; an applied magnetic field creates an induced magnetic field in them in the opposite direction, causing a repulsive force. In contrast, paramagnetic and ferromagnetic materials are attracted by a magnetic field. Oxyhemoglobin is diamagnetic in nature, whereas deoxyhemoglobin is paramagnetic. The paramagnetic deoxyhemoglobin serves as an intrinsic contrast agent on SWI sequences, and is low in signal. This causes magnetic field inhomogeneity due to two effects: A reduction of T2* and a phase difference between the vessel and its surrounding tissue. This property also forms the basic principle for blood oxygen level dependent functional and venographic imaging.
Paramagnetic substances display positive phase shift in left-handed MR systems such as the Avanto system of Siemens magnets (Erlangen, Germany). Hence, the phase images are particularly useful for differentiating between paramagnetic susceptibility effects of blood products such as deoxygenated hemoglobin, intracellular methemoglobin, hemosiderin and ferritin (positive shift) and diamagnetic effects of calcium (negative or no shift)[7,8]. Unfortunately, ferrocalcinosis may lead to confusing signal intensity patterns as even basal ganglia “calcification” is often a mixture of paramagnetic iron and diamagnetic calcium. Yamada et al[8] demonstrated that all basal ganglia calcifications show a paramagnetic susceptibility effect, whereas other calcifications located outside the basal ganglia (such as choroid plexus or dural calcifications) exhibit exclusively a diamagnetic susceptibility effect. Iron accumulation in brain not only occurs in aging but is also encountered in diverse neurodegenerative diseases.
SWI sequences have some intrinsic disadvantages. Undesirable magnetic susceptibility sources that cause artifacts occuring at air-tissue interfaces such as the areas adjacent to the temporal bone and sinuses limit investigation of these regions. Also the blooming artifact, a useful sign for detecting sources of field inhomogeneity, may sometimes lead to extreme tissue signal cancellation and loss of anatomical borders[4].
CLINICAL APPLICATIONS
Cerebral amyloid angiopathy
Cerebral amyloid angiopathy (CAA) is a small vessel disease characterized by amyloid β protein deposition within the cerebral arterioles leading to fibrinoid necrosis and vessel fragility. CAA causes microhemorrhages in and around the arteriole vessel wall extending into the parenchyma[9]. CAA is a major cause of primary lobar intracranial hemorrhage and cerebral microhemorrhages in the elderly[10]. CT and routine MRI techniques are usually not able to detect cerebral microbleeds; however, SWI with its unique sensitivity to susceptibility effects, clearly demonstrates lobar and microhemorrhages predominantly in the frontal and parietal cortical and subcortical regions (Figure 1). In contrast, microhemorrhages resulting from hypertensive or atherosclerotic microangiopathy have a predilection of deep gray matter or the infratentorial location (Figure 2). CAA is also manifested by white matter hyperintensities on MRI sequences which may be accompanied clinically by cognitive impairment[11]. Detection of two or more lobar hemorrhages of any duration, high signal intensity changes in the white matter and multiple cerebral microbleeds at the corticomedullary junction are highly suspicious for CAA (10) (Figure 1). Linn et al[12] have highlighted the presence of hemosiderosis on the pial surface of the brain, likely from the leakage of blood products from repetitive superficial hemorrhages in as much as 35% of CAA cases.
Hypertensive cerebral angiopathy
Hypertensive cerebral angiopathy may also be characterized by multiple silent cerebral microhemorrhages. Unlike CAA, cerebral microhemorrhages associated with chronic systemic hypertension are more commonly found in the thalamus, basal ganglia, cerebellum and pons[10] (Figure 2). These hypertensive cerebral microhemorrhages are a risk factor for development of a subsequent intracerebral macrohematomas/lobar hemorrhages[13]. The number of cerebral microhemorrhages corresponds also with blood pressure levels. Such micro-and macrohemorrhages are exquisitely well-demonstrated by SWI particularly with acute deoxyhemoglobin or chronic hemosiderin.
TRAUMATIC BRAIN INJURIES
Diffuse axonal injury (DAI) is a type of traumatic brain injury, in which torsional forces generated by rapid acceleration or deceleration of the head cause shearing of axons. Areas most vulnearable to shear injury include the cerebral gray-white matter junction, splenium of the corpus callosum, basal ganglia and dorsolateral brainstem[10]. The extent of the axonal injury has been shown to correlate with a poor prognosis, as do parenchymal hemorrhages[14]. Recent studies have shown that SWI is more sensitive than CT or GE sequences in terms of detecting suspected hemorrhagic DAI[15]. Most DAI patients have small punctate hemorrhages located in the deep subcortical white matter[16] (Figure 3). Tong et al[17,18] and Babikian et al[19] demonstrated that SWI is 3-6 times more sensitive than T2* GE sequences in terms of detecting the number, size, volume and distribution of hemorrhagic lesions seen in DAI cases. Because of this, the previously held concept of “non-hemorrhagic shearing injury” has largely been debunked. Those formerly “bland lesions” of DAI are now shown to have microbleeds on SWI. Brain stem involvement in DAI patients is also a very important predictor that determines the long-term outcome[20]. Mittal et al[16] demonstrated that SWI was more helpful in detecting traumatic lesions occuring in the brainstem than any other MRI sequence, and revealed intraventricular and subarachnoid hemorrhage, invisible on CT. Long term hemosiderosis from recurrent traumatic bleeds (which may occur in non-accidental trauma) is also best detected on SWI. Epidural and subdural hematomas can also be demonstrated well on SWI sequences as long as air-bone interfaces do not lead to masking artifacts.
CNS VASCULAR MALFORMATIONS
True arteriovascular malformations (AVMs) usually are present at birth and can become large with time. These AVMs are characterized by their high-flow and therefore can usually be detected by conventional MRI/MR angiography techniques. In contrast, low-flow vascular malformations including cerebral cavernous malformations (CCMs), developmental venous anomalies (DVAs) and CaTe (capillary telengiectasias) may be inapparent on fast spin echo (FSE) MRI/MR angiography techniques because they mainly contain slow-flow small vessels. Although T2* weighted GE imaging is capable of detecting small venous structures and hemosiderin deposition in cavernomas and CaTes, the incorporation of the magnitude and phase information in SWI provides improved sensitivity for identifying low-flow vascular malformations that are undetectable on GE sequences[21,22]. Lee et al[21] showed that SWI is the ideal imaging sequence for screening patients who have a high clinical suspicion of low-flow vascular malformations. These lesions may be responsible for cryptogenic epilepsy, recurrent subarachnoid hemorrhage and/or hemosiderosis, and hemorrhagic injury to cranial nerves. Because the incidence of hemorrhage from occult cerebrovascular malformations is contingent on whether they have ever bled, using SWI to detect previous bleeding helps prognosticate on future risk[23].
CCMs are composed of abnormally enlarged capillary cavities surrounded by a single layer of endothelium without intervening with brain parenchyma and comprise 10%-20% of all cerebrovascular malformations[24]. The MRI findings of CCMs are variable, depending on the presence of calcification and hemorrhage within the lesions, but they typically show a mixed signal intensity, usually recognized as “popcorn-like” with a central reticulated core surrounded by a peripheral rim of hemosiderin[15] (Figure 4). Since recurrent microhemorhages occur in the CCM lesions, they may contain deoxyhemoglobin acutely or hemosiderin chronicly, both dark on SWI[25,26] (Figure 5). Symptomatic, growing and recurrently hemorrhagic CCMs are considered for surgical resection.
DVAs are the most common type of cerebral vascular malformations (≤ 60%) and are often discovered incidentally during routine MRI examinations[27]. A DVA consists of radially arranged venous structures converging to a centrally located venous trunk, which drains normal brain parenchyma[28]. They are mainly asymptomatic lesions, do not often bleed, and neurosurgical intervention is largely contraindicated due to the risk of venous infarction[29]. However, they have a high association with other vascular malformations, especially CCMs. SWI better shows the collector (head of Medusa) and deep medullary veins (snake hair of Medusa) than T1W contrast enhanced images by virtue of the low intensity of the dark veins on miniIP images (Figure 6).
CaTes are asymptomatic small vascular malformations typically ranging from several milimeters to 2 cm in size, primarly found in the pons. They may occur sporadically or may be seen with syndromes like hereditary hemorrhagic telangiectasia or after radiation therapy[30]. They are characterized by faint contrast enhancement on T1W images and therefore can be easily missed. On SWI, they can be readily identified as hypointense lesions, from deoxyhemoglobin or hemosiderin deposited in this low-flow vascular malformation (Figure 7).
Sturge-Weber syndrome (SWS) is a neurocutaneous disorder, typically seen in children and characterized by a cutaneous angioma, glaucoma and leptomeningial venous angiomatosis[31]. The imaging findings consist of unilateral cerebral atrophy, cortical “tram-track” calcifications, impaired cortical venous outflow and abnormal deep venous collaterals. SWI has been found to be superior to post gadolinium-enhanced T1WI in characterizing calcification, abnormal periventricular and transmedullary veins, cortical gyriform hypointensities and gray-white matter abnormalities (Figure 8)[22], but enhanced T1W images depict the leptomeningial angiomatosis and enlarged choroid plexus more clearly.
Cerebral venous sinus thrombosis and venous infarction
Patients with cerebral venous sinus thrombosis (CVST) may present with headaches or non-specific signs due to increased intracranial pressure (ICP). Remaining undiagnosed, it can become deadly if it progresses to malignant increased ICP[32]. An acute CVST shows deoxyhemoglobin in the involved veins, seen as prominent hypointense signal intensity areas with “blooming” artifact on SWI (Figure 9). SWI may demonstrate engorgement of the venous system as an early sign of CVST and can also show the associated parenchymal hemorrhage which occurs in 73% of venous infarctions[33].
ARTERIAL STROKE
Acute cerebral infarct with or without hemorrhage occurs due to thromboembolism or atherosclerotic stenosis of a vessel. Vascular occlusion causes a susceptibility change by decreasing the arterial flow, and increases pooling of deoxygenated blood, thus leading to a high concentration of deoxyhemoglobin[34]. In the setting of acute stroke, such conversion to deoxhyhemoglobin can occur as early as 2 h after the onset of symptoms.
In the setting of stroke, SWI assists in identifying: (1) Hemorrhages within the infarct region, thus enabling the differentiation of a hemorrhagic from a bland ischemic stroke. Many studies have also proven that SWI is more sensitive in revealing hemorrhage within the acute infarct regions than CT and 2D GE T2* weighted sequences[35,36]. SWI can also detect acute subarachnoid hemorrhage and is very sensitive to subacute and chronic subarachnoid hemorrhages, sometimes missed by CT and FLAIR[3] (Figure 10); (2) Prominent hypointense draining veins within areas of impaired perfusion (Figure 11). The visualization of these prominent veins allows for the identification of diffusion-perfusion mismatch representing penumbral brain tissue in a different fashion than current perfusion weighted imaging techniques[16]. The oxygen extraction fraction (OEF) which reflects the ratio of deoxyhemoglobin to oxyhemoglobin in the capillaries and veins, is significantly increased in the penumbra following occlusion of the artery. This high OEF in cortical veins is presumably responsible for the increased conspicuity in the infarct region[30,36]; (3) Acute intra-arterial thrombus: The susceptibility vessel sign (SVS) is defined as the presence of hypointensity from scute deoxyhemoglobin thrombus within the intracranial arteries in which the diameter of the hypointense vessel exceeds the contralateral vessel diameter[37,38] (Figures 12 and 13). Lingegowda et al[39] found an 82% sensitivity and 100% specificity for the SVS in the determination of all acute major intracranial occlusions. They also showed that SVS is more sensitive and specific than the hyperdense artery sign on CT[40,41] and the hyperintense vessel sign on FLAIR images for intracranial artery occlusions. Huang et al[42] found that patients with negative prominent veins and positive susceptibility vessel sign exhibited poor outcomes; and (4) Hemorrhagic transformation of acute ischemic infarction: Approximately 20%-40% of patients bleed within the first week after a stroke[43] (Figure 14). Old microhemorrhages in a stroke patient may presage the vulnerability of the vascular system[44]. In patients with a small number of microhemorrhages (< 5), thrombolytic therapy can be applied safely, whereas patients with large numbers of microhemorrhages (> 5) have a great risk for potential hemorrhagic transformation from thrombolytic therapy[45-49]. Huang et al[42] showed that microhemorrhages were significantly associated with later hemorrhagic transformation. SWI is able to detect microhemorrhages within the infarct region more accurately than T2* weighted GE sequences.
NEURODEGENERATIVE DISEASES
It is widely accepted that iron deposition in the brain increases with normal aging, particularly in the basal ganglia region primarily in the form of ferritin and ferrocalcinosis (Figure 15). Increased iron levels in the CNS are encountered in a variety of neurodegenerative diseases, superimposed on the normal senescent iron increase[50,51] in the globus pallidum, substantia nigra, red nucleus, subthalamic nucleus and dentate nucleus. Increased iron deposition is found in Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, Multiple sclerosis (MS), Amyotrophic lateral sclerosis, Hallervorden-Spatz syndrome, Wilson’s Disease (copper) and Pantothenate kinase-associated neurodegeneration (PKAN)[52] (Table 5). In neurodegenerative diseases, the ability to measure the amount of ferritin in the brain may help predict prognosis, disease progression and treatment outcomes.
Table 5.
Entity | Increased iron location | Ref. |
Parkinson’s disease | SN, pars compacta, brainstem | [53] |
Alzheimer’s disease | Hippocampus, GP | [54] |
PKAN | GP, SN sparing DN | [55] |
Infantile neuroaxonal dystrophy | GP, SN, DN | [55] |
Neuroferritinopathy | GP, P, DN with cavitation | [55] |
Aceruloplasminemia | BG, thalami with no cavitation | [55] |
Huntington’s disease | CN, P | [56] |
Progressive MCI versus stable MCI | Right GP, SN | [57] |
Multiple sclerosis | CN, P and thalamic pulvinar | [60] |
CN: Caudate nucleus; GP: Globus Pallidus; P: Putamen; BG: Basal Ganglia; SN: Substantia Nigra; DN: Dentate nucleus; PKAN: Pantothenate kinase-associated neurodegeneration.
SWI shows differences in stable and progressive MCI[57]. Fourteen percent of controls, 33% of patients with stable MCI and 54% of those with progressive MCI had microhemorrhages. Furthermore, the iron content in the right pallidum and right substantia nigra was greater in progressive MCI than stable MCI.
Barnaure et al[58] studied 328 cognitively normal control subjects and 71 patients with MCI using SWI on a 3T magnet to investigate the presence and distribution of cerebral microbleeds. They found no difference between the two groups in terms of cerebral microbleed prevalence, distribution and severity. The patients’ cognitive decline over an 18 mo period did not correlate with microbleeds. They concluded that microbleeds do not predict cognitive decline in advanced age.
MS affects both brain and spinal cord and is typically imaged with FLAIR and contrast-enhanced T1W images. The sensitivity of MRI in depicting MS lesions in the brain is demonstrated to be high, but its specificity remains low. SWI helps by revealing the perivenular distribution of the demyelinating lesions by showing the MS plaque surrounding the small veins[59]. This has been used to distinguish MS from SAPHO (synovitis, acne, pustulosis, hyperostosis and osteitis) syndrome white matter lesions.
Rudko et al[61] have shown that the levels of iron deposition in patients with MS correlates better with disability than MS plaque volume. They have also shown increased iron content in patients with clinically isolated syndrome (CIS).
BRAIN TUMORS
SWI can help in the grading of cerebral tumors because it provides identification of both hemorrhagic and calcified foci inside the tumors and also allows assessment of the detailed internal angioarchitecture of the tumors. High grade tumors like glioblastomas usually contain a hemorrhagic component (Figure 16)[3,62-64].
Sehgal et al[65] demonstrated that in the majority of cases, SWI was equivalent to T1W contrast-enhanced images in the grading of gliomas. The criteria used for this comparison were tumor visibility, boundaries, edema, vessels, blood products, internal architecture and image quality. Mittal et al[16] have showed that high rCBV values on PWI and high choline-creatine ratios on MR spectroscopy found in tumors exhibit a good correlation with evidence of blood products demonstrated within the tumor using SWI.
In assessing brain tumors, calcification is considered as a very important indicator. Calcification is diamagnetic, whereas hemorrhage is paramagnetic, therefore resulting in opposite signal intensities on SWI phase images[66]. For the determination of calcification in brain tumors such as oligodendrogliomas, Zulfigar et al[67] found that adding SWI sequences led to a statistically significant improvement in the sensitivity for the detection of intratumoral calcification by 53% (from 33% to 86%) but no change in specificity.
SWI can also be used to distinguish vestibular schwannomas from cerebellopontine angle meningiomas. Microhemorrhages occur with schwannomas, not found in the meningiomas[68] (Figure 17).
The dual rim sign (hyperintense inner, hypiointense outer) from the respiratorty burst of bacteria converting hemoglobin to methemoglobin has been shown to differentiate abscesses (present) from glioblastoma (absent) in the face of a ring enhancing mass[69].
QSM
QSM is a recently developed sophisticated postprocessing technique and numerically solves the inverse source-effect problem to quantify local tissue magnetic susceptibility from the major magnetic field distribution, reflected in the phase images of SWI[70]. The mapping of iron can play a crucial role in the setting of many important neurologic disorders. In early Parkinson’s disease (PD), iron elevation in the specific brain regions including the substantia nigra is a pathognomonic feature of the disease and this can be measured by QSM[71]. He et al[72] evaluated 44 early PD patients; susceptibility values within the substantia nigra and red nucleus contralateral to the most affected limb were elevated compared to a healthy control group. Bilateral substantia nigra magnetic susceptibility showed a positive correlation with disease duration[72].
Acosta-Cabronero et al[73] examined 66 patients with idiopathic PD and found increased R2* and susceptibility values in the substantia nigra, red nucleus, thalamus and globus pallidus. QSM additionally correlated with disease severity in these patients.
Moon et al[74] investigated the presence and pattern of brain iron accumulation in vascular dementia (VaD) and Alzheimer’s disease (AD) patients by means of QSM. Both in VaD and AD patients significantly higher susceptibility values were found in the caudate nucleus and putamen compared to control subjects. Age and cognitive disease severity of both patient groups were not correlated with increased iron accumulation in their basal ganglia (Figure 18).
Dominguez et al[75] measured iron accumulation in the basal ganglia in both premanifest and symptomatic Huntington’s disease (HD) patients with QSM. Both groups of patients demonstrated substantially elevated iron content in the caudate nucleus, globus pallidus and putamen compared to normal control subjects. Increased iron levels showed significant correlation with disease severity (Figure 19). QSM is also capable of quantifying elevated iron levels in the motor cortex of amyotrophic lateral sclerosis patients. Furthermore, in Wilson’s disease, iron accumulation and quantification can be demonstrated by QSM[71]. Iron chelation therapy in PD can be monitored by QSM[71]. Walsh et al[76] have shown that the deficits of patients with MS more strongly correlate with QSM values of brain iron content than the MS plaque volume (Figure 20).
CONCLUSION
SWI is a very useful imaging tool with a variety of applications in neuroradiology practice and should be included in routine protocols. As demonstrated, it is very helpful in detecting micro-and macro-hemorhages and delineating cerebral microvasculature and low-flow vascular malformations. It is regarded as a complementary, valuable imaging sequence in the management of stroke patients. It facilitates differentiation of calcium from hemorrhage in the brain. It is helpful in the evaluation of traumatic brain injury patients and aids in the characterization and grading of cerebral tumors. QSM can shed light on many neurodegenerative disorders in a more rigorous statistical way by assessing brain iron content. Further investigations are needed for expanding the roles of SWI and QSM in neuroradiology clinical and research arenas.
ACKNOWLEDGMENTS
Our thanks to Xu Li, PhD, from Johns Hopkins Medical Institution, Radiology and Radiological Sciences, Baltimore, Maryland, United States, for his support in providing the QSM part figures (18 and 19) of our article. We are also grateful to the Korean Journal of Radiology for their permission of Figure 20.
Footnotes
Conflict-of-interest statement: No potential conflicts of interest.
Manuscript source: Unsolicited manuscript
Peer-review started: March 17, 2018
First decision: April 4, 2018
Article in press: April 20, 2018
Specialty type: Radiology, nuclear medicine and medical imaging
Country of origin: Turkey
Peer-review report classification
Grade A (Excellent): A
Grade B (Very good): 0
Grade C (Good): C, C
Grade D (Fair): 0
Grade E (Poor): 0
P- Reviewer: Sergi CM, Schoenhagen P, Ueda H S- Editor: Ji FF L- Editor: A E- Editor: Tan WW
Contributor Information
Ahmet Mesrur Halefoglu, Department of Radiology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, Istanbul 34371, Turkey.
David Mark Yousem, Division of Neuroradiology, Department of Radiology, Johns Hopkins Medical Institution, Baltimore, MI 21287, United States.
References
- 1.Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology. 1997;204:272–277. doi: 10.1148/radiology.204.1.9205259. [DOI] [PubMed] [Google Scholar]
- 2.Reichenbach JR, Haacke EM. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed. 2001;14:453–467. doi: 10.1002/nbm.722. [DOI] [PubMed] [Google Scholar]
- 3.Thomas B, Somasundaram S, Thamburaj K, Kesavadas C, Gupta AK, Bodhey NK, Kapilamoorthy TR. Clinical applications of susceptibility weighted MR imaging of the brain - a pictorial review. Neuroradiology. 2008;50:105–116. doi: 10.1007/s00234-007-0316-z. [DOI] [PubMed] [Google Scholar]
- 4.Gasparotti R, Pinelli L, Liserre R. New MR sequences in daily practice: susceptibility weighted imaging. A pictorial essay. Insights Imaging. 2011;2:335–347. doi: 10.1007/s13244-011-0086-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI) Magn Reson Med. 2004;52:612–618. doi: 10.1002/mrm.20198. [DOI] [PubMed] [Google Scholar]
- 6.Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol. 2009;30:19–30. doi: 10.3174/ajnr.A1400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol. 2005;26:736–742. [PMC free article] [PubMed] [Google Scholar]
- 8.Yamada N, Imakita S, Sakuma T, Takamiya M. Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. Radiology. 1996;198:171–178. doi: 10.1148/radiology.198.1.8539373. [DOI] [PubMed] [Google Scholar]
- 9.Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke. 2004;35:1415–1420. doi: 10.1161/01.STR.0000126807.69758.0e. [DOI] [PubMed] [Google Scholar]
- 10.Blitstein MK, Tung GA. MRI of cerebral microhemorrhages. AJR Am J Roentgenol. 2007;189:720–725. doi: 10.2214/AJR.07.2249. [DOI] [PubMed] [Google Scholar]
- 11.Smith EE, Gurol ME, Eng JA, Engel CR, Nguyen TN, Rosand J, Greenberg SM. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology. 2004;63:1606–1612. doi: 10.1212/01.wnl.0000142966.22886.20. [DOI] [PubMed] [Google Scholar]
- 12.Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, van Buchem MA, Bruckmann H, Greenberg SM. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74:1346–1350. doi: 10.1212/WNL.0b013e3181dad605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Tsushima Y, Tanizaki Y, Aoki J, Endo K. MR detection of microhemorrhages in neurologically healthy adults. Neuroradiology. 2002;44:31–36. doi: 10.1007/s002340100649. [DOI] [PubMed] [Google Scholar]
- 14.Medana IM, Esiri MM. Axonal damage: a key predictor of outcome in human CNS diseases. Brain. 2003;126:515–530. doi: 10.1093/brain/awg061. [DOI] [PubMed] [Google Scholar]
- 15.Schaefer PW, Huisman TA, Sorensen AG, Gonzalez RG, Schwamm LH. Diffusion-weighted MR imaging in closed head injury: high correlation with initial glasgow coma scale score and score on modified Rankin scale at discharge. Radiology. 2004;233:58–66. doi: 10.1148/radiol.2323031173. [DOI] [PubMed] [Google Scholar]
- 16.Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol. 2009;30:232–252. doi: 10.3174/ajnr.A1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tong KA, Ashwal S, Holshouser BA, Shutter LA, Herigault G, Haacke EM, Kido DK. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology. 2003;227:332–339. doi: 10.1148/radiol.2272020176. [DOI] [PubMed] [Google Scholar]
- 18.Tong KA, Ashwal S, Holshouser BA, Nickerson JP, Wall CJ, Shutter LA, Osterdock RJ, Haacke EM, Kido D. Diffuse axonal injury in children: clinical correlation with hemorrhagic lesions. Ann Neurol. 2004;56:36–50. doi: 10.1002/ana.20123. [DOI] [PubMed] [Google Scholar]
- 19.Babikian T, Freier MC, Tong KA, Nickerson JP, Wall CJ, Holshouser BA, Burley T, Riggs ML, Ashwal S. Susceptibility weighted imaging: neuropsychologic outcome and pediatric head injury. Pediatr Neurol. 2005;33:184–194. doi: 10.1016/j.pediatrneurol.2005.03.015. [DOI] [PubMed] [Google Scholar]
- 20.Mannion RJ, Cross J, Bradley P, Coles JP, Chatfield D, Carpenter A, Pickard JD, Menon DK, Hutchinson PJ. Mechanism-based MRI classification of traumatic brainstem injury and its relationship to outcome. J Neurotrauma. 2007;24:128–135. doi: 10.1089/neu.2006.0127. [DOI] [PubMed] [Google Scholar]
- 21.Lee BC, Vo KD, Kido DK, Mukherjee P, Reichenbach J, Lin W, Yoon MS, Haacke M. MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. AJNR Am J Neuroradiol. 1999;20:1239–1242. [PMC free article] [PubMed] [Google Scholar]
- 22.Barnes SR, Haacke EM. Susceptibility-weighted imaging: clinical angiographic applications. Magn Reson Imaging Clin N Am. 2009;17:47–61. doi: 10.1016/j.mric.2008.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Yousem DM, Flamm ES, Grossman RI. Comparison of MR imaging with clinical history in the identification of hemorrhage in patients with cerebral arteriovenous malformations. AJNR Am J Neuroradiol. 1989;10:1151–1154. [PMC free article] [PubMed] [Google Scholar]
- 24.Lehnhardt FG, von Smekal U, Rückriem B, Stenzel W, Neveling M, Heiss WD, Jacobs AH. Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation. Arch Neurol. 2005;62:653–658. doi: 10.1001/archneur.62.4.653. [DOI] [PubMed] [Google Scholar]
- 25.Cooper AD, Campeau NG, Meissner I. Susceptibility-weighted imaging in familial cerebral cavernous malformations. Neurology. 2008;71:382. doi: 10.1212/01.wnl.0000319659.86629.c8. [DOI] [PubMed] [Google Scholar]
- 26.Abla A, Wait SD, Uschold T, Lekovic GP, Spetzler RF. Developmental venous anomaly, cavernous malformation, and capillary telangiectasia: spectrum of a single disease. Acta Neurochir (Wien) 2008;150:487–489; discussion 489. doi: 10.1007/s00701-008-1570-5. [DOI] [PubMed] [Google Scholar]
- 27.Abe T, Singer RJ, Marks MP, Norbash AM, Crowley RS, Steinberg GK. Coexistence of occult vascular malformations and developmental venous anomalies in the central nervous system: MR evaluation. AJNR Am J Neuroradiol. 1998;19:51–57. [PMC free article] [PubMed] [Google Scholar]
- 28.Töpper R, Jürgens E, Reul J, Thron A. Clinical significance of intracranial developmental venous anomalies. J Neurol Neurosurg Psychiatry. 1999;67:234–238. doi: 10.1136/jnnp.67.2.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol. 2008;29:9–17. doi: 10.3174/ajnr.A0786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Comi AM. Update on Sturge-Weber syndrome: diagnosis, treatment, quantitative measures, and controversies. Lymphat Res Biol. 2007;5:257–264. doi: 10.1089/lrb.2007.1016. [DOI] [PubMed] [Google Scholar]
- 31.Hinman JM, Provenzale JM. Hypointense thrombus on T2-weighted MR imaging: a potential pitfall in the diagnosis of dural sinus thrombosis. Eur J Radiol. 2002;41:147–152. doi: 10.1016/s0720-048x(01)00365-5. [DOI] [PubMed] [Google Scholar]
- 32.Mammen EF. Pathogenesis of venous thrombosis. Chest. 1992;102:640S–644S. doi: 10.1378/chest.102.6_supplement.640s. [DOI] [PubMed] [Google Scholar]
- 33.Khandelwal N, Agarwal A, Kochhar R, Bapuraj JR, Singh P, Prabhakar S, Suri S. Comparison of CT venography with MR venography in cerebral sinovenous thrombosis. AJR Am J Roentgenol. 2006;187:1637–1643. doi: 10.2214/AJR.05.1249. [DOI] [PubMed] [Google Scholar]
- 34.Viallon M, Altrichter S, Pereira VM, Nguyen D, Sekoranja L, Federspiel A, Kulcsar Z, Sztajzel R, Ouared R, Bonvin C, et al. Combined use of pulsed arterial spin-labeling and susceptibility-weighted imaging in stroke at 3T. Eur Neurol. 2010;64:286–296. doi: 10.1159/000321162. [DOI] [PubMed] [Google Scholar]
- 35.Hermier M, Nighoghossian N. Contribution of susceptibility-weighted imaging to acute stroke assessment. Stroke. 2004;35:1989–1994. doi: 10.1161/01.STR.0000133341.74387.96. [DOI] [PubMed] [Google Scholar]
- 36.Cheng AL, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M, Smith EE. Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke. 2013;44:2782–2786. doi: 10.1161/STROKEAHA.113.002267. [DOI] [PubMed] [Google Scholar]
- 37.Flacke S, Urbach H, Keller E, Träber F, Hartmann A, Textor J, Gieseke J, Block W, Folkers PJ, Schild HH. Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology. 2000;215:476–482. doi: 10.1148/radiology.215.2.r00ma09476. [DOI] [PubMed] [Google Scholar]
- 38.Rovira A, Orellana P, Alvarez-Sabín J, Arenillas JF, Aymerich X, Grivé E, Molina C, Rovira-Gols A. Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology. 2004;232:466–473. doi: 10.1148/radiol.2322030273. [DOI] [PubMed] [Google Scholar]
- 39.Lingegowda D, Thomas B, Vaghela V, Hingwala DR, Kesavadas C, Sylaja PN. 'Susceptibility sign' on susceptibility-weighted imaging in acute ischemic stroke. Neurol India. 2012;60:160–164. doi: 10.4103/0028-3886.96389. [DOI] [PubMed] [Google Scholar]
- 40.Kesavadas C, Santhosh K, Thomas B. Susceptibility weighted imaging in cerebral hypoperfusion-can we predict increased oxygen extraction fraction? Neuroradiology. 2010;52:1047–1054. doi: 10.1007/s00234-010-0733-2. [DOI] [PubMed] [Google Scholar]
- 41.Assouline E, Benziane K, Reizine D, Guichard JP, Pico F, Merland JJ, Bousser MG, Chabriat H. Intra-arterial thrombus visualized on T2* gradient echo imaging in acute ischemic stroke. Cerebrovasc Dis. 2005;20:6–11. doi: 10.1159/000086120. [DOI] [PubMed] [Google Scholar]
- 42.Huang P, Chen CH, Lin WC, Lin RT, Khor GT, Liu CK. Clinical applications of susceptibility weighted imaging in patients with major stroke. J Neurol. 2012;259:1426–1432. doi: 10.1007/s00415-011-6369-2. [DOI] [PubMed] [Google Scholar]
- 43.Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, Leary MC, Starkman S, Gobin YP, Jahan R, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke. 2002;33:95–98. doi: 10.1161/hs0102.101792. [DOI] [PubMed] [Google Scholar]
- 44.Chalela JA, Kang DW, Warach S. Multiple cerebral microbleeds: MRI marker of a diffuse hemorrhage-prone state. J Neuroimaging. 2004;14:54–57. [PubMed] [Google Scholar]
- 45.Kesavadas C, Thomas B, Pendharakar H, Sylaja PN. Susceptibility weighted imaging: does it give information similar to perfusion weighted imaging in acute stroke? J Neurol. 2011;258:932–934. doi: 10.1007/s00415-010-5843-6. [DOI] [PubMed] [Google Scholar]
- 46.Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, Hill MD, Patronas N, Latour L, Warach S. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293–298. doi: 10.1016/S0140-6736(07)60151-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Wycliffe ND, Choe J, Holshouser B, Oyoyo UE, Haacke EM, Kido DK. Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography: a retrospective study. J Magn Reson Imaging. 2004;20:372–377. doi: 10.1002/jmri.20130. [DOI] [PubMed] [Google Scholar]
- 48.von Kummer R. MRI: the new gold standard for detecting brain hemorrhage? Stroke. 2002;33:1748–1749. doi: 10.1161/01.str.0000019882.06696.d6. [DOI] [PubMed] [Google Scholar]
- 49.Wintermark M, Sanelli PC, Albers GW, Bello JA, Derdeyn CP, Hetts SW, Johnson MH, Kidwell CS, Lev MH, Liebeskind DS, et al. Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery. J Am Coll Radiol. 2013;10:828–832. doi: 10.1016/j.jacr.2013.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, Khan A, Ayaz M, Kirsch W, Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging. 2005;23:1–25. doi: 10.1016/j.mri.2004.10.001. [DOI] [PubMed] [Google Scholar]
- 51.Harder SL, Hopp KM, Ward H, Neglio H, Gitlin J, Kido D. Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging. AJNR Am J Neuroradiol. 2008;29:176–183. doi: 10.3174/ajnr.A0770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Hecht MJ, Fellner C, Schmid A, Neundörfer B, Fellner FA. Cortical T2 signal shortening in amyotrophic lateral sclerosis is not due to iron deposits. Neuroradiology. 2005;47:805–808. doi: 10.1007/s00234-005-1421-5. [DOI] [PubMed] [Google Scholar]
- 53.Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology. 2008;70:1411–1417. doi: 10.1212/01.wnl.0000286384.31050.b5. [DOI] [PubMed] [Google Scholar]
- 54.Schenck JF, Zimmerman EA, Li Z, Adak S, Saha A, Tandon R, Fish KM, Belden C, Gillen RW, Barba A, et al. High-field magnetic resonance imaging of brain iron in Alzheimer disease. Top Magn Reson Imaging. 2006;17:41–50. doi: 10.1097/01.rmr.0000245455.59912.40. [DOI] [PubMed] [Google Scholar]
- 55.McNeill A, Birchall D, Hayflick SJ, Gregory A, Schenk JF, Zimmerman EA, Shang H, Miyajima H, Chinnery PF. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology. 2008;70:1614–1619. doi: 10.1212/01.wnl.0000310985.40011.d6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.van Bergen JM, Hua J, Unschuld PG, Lim IA, Jones CK, Margolis RL, Ross CA, van Zijl PC, Li X. Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease. AJNR Am J Neuroradiol. 2016;37:789–796. doi: 10.3174/ajnr.A4617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Haller S, Bartsch A, Nguyen D, Rodriguez C, Emch J, Gold G, Lovblad KO, Giannakopoulos P. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibility-weighted MR imaging assessment. Radiology. 2010;257:764–773. doi: 10.1148/radiol.10100612. [DOI] [PubMed] [Google Scholar]
- 58.Barnaure I, Montandon ML, Rodriguez C, Herrmann F, Lövblad KO, Giannakopoulos P, Haller S. Clinicoradiologic Correlations of Cerebral Microbleeds in Advanced Age. AJNR Am J Neuroradiol. 2017;38:39–45. doi: 10.3174/ajnr.A4956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Tan IL, van Schijndel RA, Pouwels PJ, van Walderveen MA, Reichenbach JR, Manoliu RA, Barkhof F. MR venography of multiple sclerosis. AJNR Am J Neuroradiol. 2000;21:1039–1042. [PMC free article] [PubMed] [Google Scholar]
- 60.Haacke EM, Ayaz M, Khan A, Manova ES, Krishnamurthy B, Gollapalli L, Ciulla C, Kim I, Petersen F, Kirsch W. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging. 2007;26:256–264. doi: 10.1002/jmri.22987. [DOI] [PubMed] [Google Scholar]
- 61.Rudko DA, Solovey I, Gati JS, Kremenchutzky M, Menon RS. Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging. Radiology. 2014;272:851–864. doi: 10.1148/radiol.14132475. [DOI] [PubMed] [Google Scholar]
- 62.Rauscher A, Sedlacik J, Fitzek C, Walter B, Hochstetter A, Kalff R, Kaiser WA, Reichenbach JR. High resolution susceptibility weighted MR-imaging of brain tumors during the application of a gaseous agent. Rofo. 2005;177:1065–1069. doi: 10.1055/s-2005-858428. [DOI] [PubMed] [Google Scholar]
- 63.Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, Kido DK, Xu Y, Neelavalli J, Haddar D, Reichenbach JR. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging. 2005;22:439–450. doi: 10.1002/jmri.20404. [DOI] [PubMed] [Google Scholar]
- 64.Hammond KE, Lupo JM, Xu D, Metcalf M, Kelley DA, Pelletier D, Chang SM, Mukherjee P, Vigneron DB, Nelson SJ. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage. 2008;39:1682–1692. doi: 10.1016/j.neuroimage.2007.10.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, Barger G, Hu J, Xu Y, Prabhakaran KP, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging. 2006;24:41–51. doi: 10.1002/jmri.20598. [DOI] [PubMed] [Google Scholar]
- 66.Wu Z, Mittal S, Kish K, Yu Y, Hu J, Haacke EM. Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging. 2009;29:177–182. doi: 10.1002/jmri.21617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Zulfiqar M, Dumrongpisutikul N, Intrapiromkul J, Yousem DM. Detection of intratumoral calcification in oligodendrogliomas by susceptibility-weighted MR imaging. AJNR Am J Neuroradiol. 2012;33:858–864. doi: 10.3174/ajnr.A2862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Thamburaj K, Radhakrishnan VV, Thomas B, Nair S, Menon G. Intratumoral microhemorrhages on T2*-weighted gradient-echo imaging helps differentiate vestibular schwannoma from meningioma. AJNR Am J Neuroradiol. 2008;29:552–557. doi: 10.3174/ajnr.A0887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Toh CH, Wei KC, Chang CN, Hsu PW, Wong HF, Ng SH, Castillo M, Lin CP. Differentiation of pyogenic brain abscesses from necrotic glioblastomas with use of susceptibility-weighted imaging. AJNR Am J Neuroradiol. 2012;33:1534–1538. doi: 10.3174/ajnr.A2986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Reichenbach JR, Schweser F, Serres B, Deistung A. Quantitative Susceptibility Mapping: Concepts and Applications. Clin Neuroradiol. 2015;25 Suppl 2:225–230. doi: 10.1007/s00062-015-0432-9. [DOI] [PubMed] [Google Scholar]
- 71.Eskreis-Winkler S, Zhang Y, Zhang J, Liu Z, Dimov A, Gupta A, Wang Y. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning. NMR Biomed. 2017;30 doi: 10.1002/nbm.3668. [DOI] [PubMed] [Google Scholar]
- 72.He N, Ling H, Ding B, Huang J, Zhang Y, Zhang Z, Liu C, Chen K, Yan F. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping. Hum Brain Mapp. 2015;36:4407–4420. doi: 10.1002/hbm.22928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Acosta-Cabronero J, Williams GB, Cardenas-Blanco A, Arnold RJ, Lupson V, Nestor PJ. In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. PLoS One. 2013;8:e81093. doi: 10.1371/journal.pone.0081093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Moon Y, Han SH, Moon WJ. Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging. J Alzheimers Dis. 2016;51:737–745. doi: 10.3233/JAD-151037. [DOI] [PubMed] [Google Scholar]
- 75.Domínguez JF, Ng AC, Poudel G, Stout JC, Churchyard A, Chua P, Egan GF, Georgiou-Karistianis N. Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study. J Neurol Neurosurg Psychiatry. 2016;87:545–549. doi: 10.1136/jnnp-2014-310183. [DOI] [PubMed] [Google Scholar]
- 76.Walsh AJ, Blevins G, Lebel RM, Seres P, Emery DJ, Wilman AH. Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease. Radiology. 2014;270:186–196. doi: 10.1148/radiol.13130474. [DOI] [PubMed] [Google Scholar]